These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1780293)

  • 21. [Clinico-immunological evaluation of using T-activin in children with obstructive bronchitis (data of immediate and late studies)].
    Eiubova AA; Budagov FG; Rzakulieva DM
    Pediatriia; 1991; (1):108. PubMed ID: 2041682
    [No Abstract]   [Full Text] [Related]  

  • 22. Sensitization of T lymphocytes to thyroid antigen in autoimmune thyroid disease as demonstrated by the monocyte procoagulant activity test.
    Iitaka M; Bernstein J; Gerstein HC; Iwatani Y; Row VV; Volpé R
    J Endocrinol Invest; 1986 Dec; 9(6):471-8. PubMed ID: 3494757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease.
    O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL
    J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of autoimmune thyroiditis].
    Kustova NI; Kiseleva TP
    Sov Med; 1988; (8):25-8. PubMed ID: 3059530
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chronic liver diseases: secondary thymic insufficiency and immunocorrection with T-activin].
    Sarkisian SV
    Klin Med (Mosk); 1994; 72(6):45-8. PubMed ID: 7898010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correction with T-activin of secondary immunodeficiency in inflammatory diseases of female internal genital organs].
    Pogodin OK; Samorodinova LA; Matveeva NK; Sukhikh GT
    Akush Ginekol (Mosk); 1991 Apr; (4):40-4. PubMed ID: 1862873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunobiology of thymus peptides: T-activin].
    Arion VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):98-104. PubMed ID: 3300113
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
    Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
    Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First experience with immunomodulation in septic shock.
    Josten C; Muhr G; Sistermann R
    Prog Clin Biol Res; 1989; 308():989-94. PubMed ID: 2528747
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of thymus gland peptides in chronic cholecystitis].
    Rodoman GV; Belousov IuB; Kostrova MV; Petrov OA
    Sov Med; 1991; (3):73-4. PubMed ID: 1882302
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of T-activin on the course of ischemic heart disease in cases of the development of sensitization to apoprotein B-containing lipoproteins].
    Klimov AN; Lopukhin IuM; Almazov VA; Nagornev VA; Sergeeva EG; Pigarevskiĭ PV; Ogurtsov RP; Denisenko AD; Sofronov BN; Popov VG
    Kardiologiia; 1990 Sep; 30(9):40-4. PubMed ID: 2148786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunological reactivity and the HLA system antigens in patients with autoimmune thyroiditis and nodular euthyroid goiter].
    Privalov VA; Vasil'ev SA
    Probl Endokrinol (Mosk); 1989; 35(4):22-7. PubMed ID: 2602347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
    Aichinger G; Fill H; Wick G
    Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of T-activin in viral myocarditis in animal experiments].
    Kipshidze NN; Dzhaparidze MM; Bulusashvili RV; Khuchua AV; Zbiadadze NA
    Biull Eksp Biol Med; 1988 Jun; 105(6):705-7. PubMed ID: 3260519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunogenetic indicators in protracted hepatitis and their dynamics during the treatment with T-activin].
    Stanevicha VA; Veksler KhM
    Pediatriia; 1991; (10):44-8. PubMed ID: 1787998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
    Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
    Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
    [No Abstract]   [Full Text] [Related]  

  • 37. [T-cell immunity and immunomodulators in the comprehensive treatment of diffuse toxic goiter].
    Petunina NA; Balabolkin MI; Arion VIa
    Ross Med Zh; 1992; (5-12):19-24. PubMed ID: 1286263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
    Mel'nik VP
    Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. II. Immunohistochemical studies on the thyroiditis lesion.
    Sugihara S; Maruo S; Tada T; Tsujimura T; Kohno Y; Hamaoka T; Fujiwara H
    Reg Immunol; 1989; 2(6):345-54. PubMed ID: 2485683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ultrastructural aspects in experimental immunological thyroiditis (with reference also to the behavior of hormone secretion after a single thyrotropin stimulation)].
    Pende G; Polleri A; Indiveri F; Menozzi PG; Orofino G
    Folia Endocrinol; 1970 Aug; 23(4):466-95. PubMed ID: 5537588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.